TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BEAM

Beam Therapeutics Inc

Healthcare · Biotechnology

25.00$ +1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Beam Therapeutics Inc (BEAM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.5 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BEAM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
17 316 7.4 12 14 30 7.5 8.5 9.7 114 32 0.5 156
100 140 85 87 94 101 99 102 110 5.7 11
-83 176 -77 -75 -80 -71 -91 -93 -100 108 21 0.5 30
100 140 85 87 94 101 99 102 110 99 105 95 409
25 43 27 30 27 29 28 27 27 27 34 32 120
25 43 27 30 27 29 28 27 27 126 128 127 408
-108 133 -104 -105 -107 -100 -119 -120 -127 -17 -107 -127 -378
13 12 14 12 12 11 11 9.9 7.5 39
-96 144 -99 -91 -97 -90 -109 -102 -113 244 -94 -123 -85
-17 1.4 5.4 0.0 -5.5
-96 143 -99 -91 -97 -90 -109 -102 -113 244 -94 -123 -85
-91 150 -93 -85 -91 -85 -104 -97 -107 261 -89 -125 -60

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?